Clinical Trial Update: Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia [Phase 2, Phase 3]

View source ↗

Summary

It describes a Phase 2/Phase 3 trial evaluating the efficacy and safety of tolvaptan tablets in patients with non-hypovolemic non-acute hyponatremia; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-hypovolemic Non-acute Hyponatremia | Phase 2, Phase 3 | Status: UNKNOWN